Latest news with #RafflesMedicalGroup
Yahoo
03-08-2025
- Business
- Yahoo
Raffles Medical Group First Half 2025 Earnings: EPS: S$0.017 (vs S$0.017 in 1H 2024)
Raffles Medical Group (SGX:BSL) First Half 2025 Results Key Financial Results Revenue: S$378.4m (up 3.5% from 1H 2024). Net income: S$32.1m (up 4.8% from 1H 2024). Profit margin: 8.5% (up from 8.4% in 1H 2024). The increase in margin was driven by higher revenue. EPS: S$0.017 (in line with 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Raffles Medical Group Earnings Insights Looking ahead, revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Asia. Performance of the market in Singapore. The company's shares are down 4.8% from a week ago. Risk Analysis Before you take the next step you should know about the 1 warning sign for Raffles Medical Group that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
19-06-2025
- Business
- Yahoo
While individual investors own 28% of Raffles Medical Group Ltd (SGX:BSL), private companies are its largest shareholders with 42% ownership
The considerable ownership by private companies in Raffles Medical Group indicates that they collectively have a greater say in management and business strategy A total of 2 investors have a majority stake in the company with 52% ownership Insiders own 15% of Raffles Medical Group We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Every investor in Raffles Medical Group Ltd (SGX:BSL) should be aware of the most powerful shareholder groups. With 42% stake, private companies possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Individual investors, on the other hand, account for 28% of the company's stockholders. In the chart below, we zoom in on the different ownership groups of Raffles Medical Group. See our latest analysis for Raffles Medical Group Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Raffles Medical Group already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Raffles Medical Group, (below). Of course, keep in mind that there are other factors to consider, too. We note that hedge funds don't have a meaningful investment in Raffles Medical Group. Raffles Medical Holdings Pte. Ltd. is currently the largest shareholder, with 39% of shares outstanding. In comparison, the second and third largest shareholders hold about 14% and 7.8% of the stock. Choon Yong Loo, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer. After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. Our most recent data indicates that insiders own a reasonable proportion of Raffles Medical Group Ltd. Insiders own S$274m worth of shares in the S$1.8b company. That's quite meaningful. It is good to see this level of investment. You can check here to see if those insiders have been buying recently. The general public-- including retail investors -- own 28% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. It seems that Private Companies own 42%, of the Raffles Medical Group stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company. It's always worth thinking about the different groups who own shares in a company. But to understand Raffles Medical Group better, we need to consider many other factors. To that end, you should be aware of the 1 warning sign we've spotted with Raffles Medical Group . If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Times
10-06-2025
- Business
- Business Times
Raffles Medical partners Chongqing hospital to enhance healthcare services
[CHONGQING, CHINA] Raffles Medical Group has inked a strategic cooperation agreement with a hospital in Chongqing, China, to deepen medical partnerships between the two. In a press statement on Tuesday (Jun 10), Raffles Medical said that the aim is to combine international expertise with local strengths and enhance the overall medical service capabilities of Chongqing. The group said it will work with the First Affiliated Hospital of Chongqing Municipality at the institutional, hospital and disciplinary levels. Under the partnership, a new healthcare collaboration ecosystem focused on value co-creation and complementary strengths will be established. For instance, the two parties will engage in reciprocal visits and exchanges for medical, nursing, technical, pharmaceutical and administrative personnel. They will also explore new models of cooperation such as dual-appointment talent systems, artificial intelligence applications, and alignment with international medical standards. 'These initiatives will inject quality-driven productivity into the sustainable development of both institutions and regional healthcare,' said the group. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Additionally, a new medical consortium will be introduced to facilitate the flow of medical resources. It will involve multidisciplinary collaboration, talent exchange and training, equipment sharing, and two-year referral mechanisms between the two. Top expert teams from both hospitals will also convene for academic exchanges and consultations of complex cases, among others, to advance disciplinary development, said Raffles Medical. 'Chongqing Model' The First Affiliated Hospital of Chongqing Municipality is a top-tier tertiary Class-A teaching hospital in China, it added. Raffles Medical's partnership with the hospital will offer a 'Chongqing Model' for international medical cooperation under the Belt and Road Initiative, noted Dr Loo Choon Yong, the group's executive chairman. The initiative – previously known as China's One Belt, One Road – is the East Asian giant's global economic plan to create regional connectivity through infrastructure development and promote world trade and economic growth. This will further consolidate Chongqing's status as an international medical hub city, said Dr Loo. Shares of Raffles Medical closed at S$0.975 on Tuesday, down 1 per cent or S$0.01, before the announcement.
Business Times
10-06-2025
- Business
- Business Times
Raffles Medical partners Chongqing hospital to strengthen healthcare services
[CHONGQING, CHINA] Raffles Medical Group has inked a strategic cooperation agreement with a hospital in Chongqing, China, to deepen medical partnerships between the two. In a press statement on Tuesday (Jun 10), Raffles Medical said that the aim is to combine international expertise with local strengths and enhance the overall medical service capabilities of Chongqing. The group said it will work with the First Affiliated Hospital of Chongqing Municipality at the institutional, hospital and disciplinary levels. Under the partnership, a new healthcare collaboration ecosystem focused on value co-creation and complementary strengths will be established. For instance, the two parties will engage in reciprocal visits and exchanges for medical, nursing, technical, pharmaceutical and administrative personnel. They will also explore new models of cooperation such as dual-appointment talent systems, artificial intelligence applications, and alignment with international medical standards. 'These initiatives will inject quality-driven productivity into the sustainable development of both institutions and regional healthcare,' said the group. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Additionally, a new medical consortium will be introduced to facilitate the flow of medical resources. It will involve multidisciplinary collaboration, talent exchange and training, equipment sharing, and two-year referral mechanisms between the two. Top expert teams from both hospitals will also convene for academic exchanges and consultations of complex cases, among others, to advance disciplinary development, said Raffles Medical. 'Chongqing Model' The First Affiliated Hospital of Chongqing Municipality is a top-tier tertiary Class-A teaching hospital in China, it added. Raffles Medical's partnership with the hospital will offer a 'Chongqing Model' for international medical cooperation under the Belt and Road Initiative, noted Dr Loo Choon Yong, the group's executive chairman. The initiative – previously known as China's One Belt, One Road – is the East Asian giant's global economic plan to create regional connectivity through infrastructure development and promote world trade and economic growth. This will further consolidate Chongqing's status as an international medical hub city, said Dr Loo. Shares of Raffles Medical closed at S$0.975 on Tuesday, down 1 per cent or S$0.01, before the announcement.
Yahoo
20-05-2025
- Business
- Yahoo
Raffles Medical Group's (SGX:BSL) Returns Have Hit A Wall
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. In light of that, when we looked at Raffles Medical Group (SGX:BSL) and its ROCE trend, we weren't exactly thrilled. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. Analysts use this formula to calculate it for Raffles Medical Group: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.074 = S$85m ÷ (S$1.5b - S$382m) (Based on the trailing twelve months to December 2024). Thus, Raffles Medical Group has an ROCE of 7.4%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 11%. Check out our latest analysis for Raffles Medical Group In the above chart we have measured Raffles Medical Group's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Raffles Medical Group for free. There hasn't been much to report for Raffles Medical Group's returns and its level of capital employed because both metrics have been steady for the past five years. It's not uncommon to see this when looking at a mature and stable business that isn't re-investing its earnings because it has likely passed that phase of the business cycle. So unless we see a substantial change at Raffles Medical Group in terms of ROCE and additional investments being made, we wouldn't hold our breath on it being a multi-bagger. This probably explains why Raffles Medical Group is paying out 55% of its income to shareholders in the form of dividends. Unless businesses have highly compelling growth opportunities, they'll typically return some money to shareholders. In summary, Raffles Medical Group isn't compounding its earnings but is generating stable returns on the same amount of capital employed. And with the stock having returned a mere 29% in the last five years to shareholders, you could argue that they're aware of these lackluster trends. So if you're looking for a multi-bagger, the underlying trends indicate you may have better chances elsewhere. One more thing, we've spotted 1 warning sign facing Raffles Medical Group that you might find interesting. For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
